Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02759575
Title A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nooshin Hashemi-Sadraei
Indications

laryngeal squamous cell carcinoma

Therapies

Cisplatin + Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.